Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q4 2023 Portfolio Holders as of 12/31/2023

Type / Class
Equity / COM CL A
Number of holders
30
Total Shares
6.83 M
Shares change
+513 K
Total reported value, excl. options
$5.92 M
Value change
+$428 K
Put/Call ratio
0.04
Number of buys
7
Number of sells
-9
Price
$0.84
CUSIP
14161Y200
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.